Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Anti angiogenesis].

Hideyuki Akaza1, Masayuki Nakagawa, Takashi Tsuruo

  • 1Dept. of Urology, University of Tsukuba.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 30, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Calcium sensing receptor expression is downregulated in gastroenteropancreatic neuroendocrine tumours via epigenetic mechanisms.

International journal of cancer·2024
Same author

3D printing: a useful tool for safe clinical practice in children with complex vasculature.

Archives of disease in childhood·2024
Same author

<i>SF3B1</i> mutations provide genetic vulnerability to copper ionophores in human acute myeloid leukemia.

Science advances·2024
Same author

[Neoadjuvant Epirubicin-Cyclophosphamide Therapy followed by Nab-Paclitaxel in Patients with Operable Breast Cancer-A Single-Center Phase Ⅱ Trial].

Gan to kagaku ryoho. Cancer & chemotherapy·2022
Same author

Enzalutamide + androgen deprivation therapy (ADT) versus flutamide + ADT in Japanese men with castration-resistant prostate cancer: AFTERCAB study.

BJUI compass·2022
Same author

A Case of Rare Matrix-producing Triple-negative Breast Carcinoma for Which Drug Response in a Patient-derived Orthotopic Xenograft Mouse Model Was Correlated With Patient Response.

Anticancer research·2021
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Developing anti-angiogenic therapies for cancer is challenging but promising. Inhibiting angiogenesis can reduce tumor growth and spread, requiring advanced research and imaging for clinical success.

Area of Science:

  • Oncology
  • Cancer Biology
  • Translational Research

Background:

  • Cancer growth and metastasis are driven by angiogenesis, the formation of new blood vessels.
  • Anti-angiogenic therapies aim to inhibit this process by targeting key factors.
  • These approaches show potential across various cancers, including prostate, gastrointestinal, lung, and breast cancer.

Purpose of the Study:

  • To review the scientific rationale and challenges of anti-angiogenic cancer therapy.
  • To explore the application of anti-angiogenesis in specific cancer types.
  • To identify critical factors for successful clinical translation.

Main Methods:

  • Review of current scientific literature and presentations on anti-angiogenic strategies.
  • Analysis of the role of angiogenesis in prostate, gastrointestinal, lung, and breast cancers.

Related Experiment Videos

  • Discussion of translational research needs and clinical development criteria.

    • Main Results:

    • Anti-angiogenic therapy development is complex, requiring multifaceted target interference.
    • Angiogenesis is crucial for the progression of several major cancer types.
    • Translational research and rigorous clinical evaluation are essential.

    Conclusions:

    • Anti-angiogenic therapies hold significant potential for treating prostate, gastrointestinal, lung, and breast cancers.
    • Successful clinical development necessitates advanced imaging techniques to assess anti-angiogenic effects.
    • Developing surrogate markers for blood vessel functionality is key to optimizing treatments.